ACHE and Parkinson disease: Another clinical trial using C‐methyl‐4‐piperidinyl propionate, which reflects cortical acetylcholinesterase activity, reported reduced posterior basal forebrain volume only in those PD patients who exhibited reduced cortical acetylcholinesterase activity.